Evolent Health (EVH) Misses Q1 EPS by 18c

Evolent Health (NYSE: EVH) reported Q1 EPS of ($0.34), $0.18 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $106.24 million versus the consensus estimate of $104.38 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Vera Bradley (VRA) Tops Q2 EPS by 10c ; Offers Guidance
• Anthropic delays planned IPO from October to November - WSJ